A Luypaerts
Katholieke Universiteit Leuven
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by A Luypaerts.
Inflammatory Bowel Diseases | 2009
Vicky De Preter; Veerle Bulteel; Peter Suenaert; K. Geboes; Gert De Hertogh; A Luypaerts; Karel Geboes; Kristin Verbeke; Paul Rutgeerts
Background: Healthy colonic mucosa uses butyrate as the major energy source. In ulcerative colitis (UC) butyrate oxidation has been shown to be disturbed, but it remains unclear whether this is a primary defect. The aim of this study was to measure mucosal butyrate oxidation in UC (involved and noninvolved colon) and in pouchitis and to study the relationship with endoscopic as well as histological disease activity. Methods: Butyrate oxidation was measured in 73 UC patients, 22 pouchitis patients, and 112 controls (95 colon, 17 ileum) by incubating biopsies with 1 mM 14C‐labeled Na‐butyrate and measuring the released 14CO2. Results: Compared with that in normal colon, butyrate oxidation was significantly impaired in endoscopically active but not in quiescent disease or uninvolved colon segments. The severity of the metabolic defect was related to histological disease activity and decreased epithelial cell height. In active pouchitis, butyrate oxidation was significantly decreased compared with that in normal ileum and excluded pouches without inflammation. The histological pouchitis score correlated significantly with butyrate oxidation. Conclusions: Active UC and pouchitis show the same inflammation‐related metabolic defect. Our data suggest that the defect is a consequence of inflammation and that pouchitis is metabolically similar to active UC.
Alimentary Pharmacology & Therapeutics | 2002
Karen Geboes; Bart Maes; A Luypaerts; Pieter Evenepoel; Paul Rutgeerts; Yvo Ghoos; Benny Geypens
Background : An inverse relationship has been established between serum magnesium and serum lipid levels. By means of breath tests, we tested the hypothesis that magnesium inhibits intraluminal lipid digestion and subsequently causes changes in lipid metabolism. We also investigated the influence of the administration of magnesium chloride on protein digestion and gastric emptying.
European Journal of Clinical Nutrition | 2011
V De Preter; Els Houben; Karen Windey; A Luypaerts; Kristin Verbeke
Background/Objectives:Lactose-[15N, 15N]-ureide is used to study the fate of the colonic urea-nitrogen metabolism. During the passage through the gastrointestinal tract, lactose ureide is hydrolysed to glucose ureide, which is absorbed to a limited extent from the small intestine and is excreted urinarily. In the present study, a procedure has been developed to quantify the urinary excretion of glucose-[15N, 15N]-ureide. In addition, urine and faecal samples obtained during a dietary intervention study with the prebiotic lactulose were retrospectively analysed.Subjects/Methods:The glucose ureide and lactose ureide content was measured by GC–MS in 19 healthy volunteers. After consumption of a standard test meal containing 75 mg lactose-[15N, 15N]-ureide, six healthy volunteers performed a fractionated 24 h urine collection to investigate the urinary excretion of glucose-[15N, 15N]-ureide. In 13 volunteers, the effect of lactulose administration on the urinary excretion of glucose-[15N, 15N]-ureide was analysed.Results:The urinary excretion of glucose-[15N, 15N]-ureide reached its maximum level in the 3–6 h urine collection and decreased in the 6–9 h urine. The label was still detectable in the 9–24 h urine collection. The cumulative excretion of 15N-labelled glucose ureide after 24 h amounted 12.91%. No significant differences in glucose-[15N, 15N]-ureide excretion were found in either of the urine fractions after administration of lactulose, compared with baseline. In none of the urine samples lactose-[15N, 15N]-ureide was detected.Conclusions:In conclusion, the results obtained in the present study indicated that the percentage dose glucose-[15N, 15N]-ureide recovered in urine is rather constant and not influenced by the presence of lactulose.
Hrc-journal of High Resolution Chromatography | 1999
Benny Geypens; D Claus; Nicole Gorris; Pieter Evenepoel; A Luypaerts; Paul Rutgeerts; Yvo Ghoos
In order to study protein digestibility by means of noninvasive tracer techniques (stable isotopes), a representative oral tracer, i.e. a stable isotope labeled protein, is needed. Therefore, egg white containing L-[ring-2H5]phenylalanine and L-[ring-2H4]tyrosine was prepared. The aim of this study was to measure the isotopic enrichment of the labeled amino acids in the egg white. The use of a standard GC-MS, based on ion trap technology was found to be a reliable technique. The enrichment of L-[ring-2H5]phenylalanine and L-[ring-2H4]tyrosine, expressed in Molar Percent (MP) amounted to 23.2 MP and 2.8 MP respectively.
Journal of Nutrition | 1998
Pieter Evenepoel; Benny Geypens; A Luypaerts; Martin Hiele; Yvo Ghoos; Paul Rutgeerts
Journal of Nutrition | 1997
Pieter Evenepoel; Martin Hiele; A Luypaerts; Benny Geypens; Johan Buyse; Eddy Decuypere; Paul Rutgeerts; Yvo Ghoos
Archaeometry | 2007
Kerlijne Romanus; Jeroen Poblome; Kristin Verbeke; A Luypaerts; Pierre A. Jacobs; Dirk E. De Vos; Marc Waelkens
Analytical and Bioanalytical Chemistry | 2008
Kerlijne Romanus; Willem Van Neer; Elena Marinova; Kristin Verbeke; A Luypaerts; Sabina Accardo; Ive Hermans; Pierre Jacobs; Dirk E. De Vos; Marc Waelkens
Microchemical Journal | 2010
Jan Baeten; Kerlijne Romanus; Patrick Degryse; Wim De Clercq; Hilde Poelman; Kristin Verbeke; A Luypaerts; Marc Walton; Pierre A. Jacobs; Dirk E. De Vos; Marc Waelkens
Gastroenterology | 1996
Bart Maes; Benny Geypens; A Luypaerts; Yvo Ghoos; Paul Rutgeerts